Clinical Trial

Xanthohumol and Viral Infections (XL)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-21; most recent amendment 2025-04-10.
Trial Details
NCT Number NCT06286657
Lead Sponsor University of Vienna
Conditions Infection Viral
Enrollment 100 participants
Start Date 2023-08-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-15